GB201904339D0 - Pharmaceutical compounds - Google Patents
Pharmaceutical compoundsInfo
- Publication number
- GB201904339D0 GB201904339D0 GBGB1904339.7A GB201904339A GB201904339D0 GB 201904339 D0 GB201904339 D0 GB 201904339D0 GB 201904339 A GB201904339 A GB 201904339A GB 201904339 D0 GB201904339 D0 GB 201904339D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceutical compounds
- pharmaceutical
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1904339.7A GB201904339D0 (en) | 2019-03-28 | 2019-03-28 | Pharmaceutical compounds |
AU2019393162A AU2019393162A1 (en) | 2018-12-06 | 2019-12-06 | Pharmaceutical compounds and their use as inhibitors of Ubiquitin Specific Protease 19 (USP19) |
KR1020217020079A KR20210102285A (en) | 2018-12-06 | 2019-12-06 | Use as pharmaceutical compounds and inhibitors of ubiquitin-specific protease 19 (USP19) |
SG11202105913RA SG11202105913RA (en) | 2018-12-06 | 2019-12-06 | Pharmaceutical compounds and their use as inhibitors of ubiquitin specific protease 19 (usp19) |
MX2021006540A MX2021006540A (en) | 2018-12-06 | 2019-12-06 | Pharmaceutical compounds and their use as inhibitors of ubiquitin specific protease 19 (usp19). |
BR112021010644-8A BR112021010644A2 (en) | 2018-12-06 | 2019-12-06 | COMPOUND, STEREOISOMER, TAUTOMER, HYDRATE, N-OXIDE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT, PHARMACEUTICAL COMPOSITION, METHODS FOR TREATMENT OF OBESITY, INSULIN RESISTANCE, TYPE II DIABETES, MUSCLE ATROPHY AND CANCER AND FOR REDUCTION OF MUSCLE MASS LOSS IN AN INDIVIDUAL , AND, USP19 INHIBITOR |
US17/299,959 US20220033397A1 (en) | 2018-12-06 | 2019-12-06 | Pharmaceutical compounds and their use as inhibitors of ubiquitin specific protease 19 (usp19) |
CA3121376A CA3121376A1 (en) | 2018-12-06 | 2019-12-06 | Pharmaceutical compounds and their use as inhibitors of ubiquitin specific protease 19 (usp19) |
EP19821176.5A EP3890829A1 (en) | 2018-12-06 | 2019-12-06 | Pharmaceutical compounds and their use as inhibitors of ubiquitin specific protease 19 (usp19) |
PCT/GB2019/053457 WO2020115501A1 (en) | 2018-12-06 | 2019-12-06 | Pharmaceutical compounds and their use as inhibitors of ubiquitin specific protease 19 (usp19) |
CN201980090768.3A CN113365696A (en) | 2018-12-06 | 2019-12-06 | Pharmaceutical compounds and their use as inhibitors of ubiquitin-specific protease 19(USP19) |
JP2021532111A JP2022512128A (en) | 2018-12-06 | 2019-12-06 | Its use as a pharmaceutical compound and ubiquitin-specific protease 19 (USP19) inhibitor |
IL283706A IL283706A (en) | 2018-12-06 | 2021-06-03 | Pharmaceutical compounds and their use as inhibitors of ubiquitin specific protease 19 (usp19) |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1904339.7A GB201904339D0 (en) | 2019-03-28 | 2019-03-28 | Pharmaceutical compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201904339D0 true GB201904339D0 (en) | 2019-05-15 |
Family
ID=66442810
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1904339.7A Ceased GB201904339D0 (en) | 2018-12-06 | 2019-03-28 | Pharmaceutical compounds |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB201904339D0 (en) |
-
2019
- 2019-03-28 GB GBGB1904339.7A patent/GB201904339D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL276232A (en) | Pharmaceutical compounds | |
GB201911928D0 (en) | Pharmaceutical compounds | |
GB201800072D0 (en) | Pharmaceutical | |
GB201800074D0 (en) | Pharmaceutical | |
GB201800073D0 (en) | Pharmaceutical | |
GB201810245D0 (en) | Pharmaceutical compounds | |
GB201911944D0 (en) | Pharmaceutical compounds | |
GB201810239D0 (en) | Pharmaceutical compounds | |
GB201819961D0 (en) | Pharmaceutical compounds | |
GB201914910D0 (en) | Pharmaceutical compounds | |
GB202020191D0 (en) | Pharmaceutical compounds | |
GB201911517D0 (en) | Pharmaceutical composition | |
GB201819960D0 (en) | Pharmaceutical compounds | |
IL291570A (en) | Pharmaceutical compounds | |
GB201801562D0 (en) | Pharmaceutical compounds | |
GB201800378D0 (en) | Pharmaceutical compounds | |
GB202010409D0 (en) | Pharmaceutical compounds | |
GB201816369D0 (en) | Pharmaceutical compounds | |
GB202111193D0 (en) | Pharmaceutical compounds | |
GB201915932D0 (en) | Pharmaceutical compounds | |
GB201915273D0 (en) | Pharmaceutical compounds | |
GB202010408D0 (en) | Pharmaceutical compounds | |
SG11202110315SA (en) | Pharmaceutical composition | |
PT3908321T (en) | Pharmaceutical composition | |
GB201901989D0 (en) | Pharmaceutical combinations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |